Trattamento del paziente con stenosi coronarica e carotidea

Size: px
Start display at page:

Download "Trattamento del paziente con stenosi coronarica e carotidea"

Transcription

1 Trattamento del paziente con stenosi coronarica e carotidea Fabrizio Tomai, MD, FACC, FESC Dept. of Cardiovasc. Sciences Interventional Cardiology Unit European & Aurelia Hospitals Rome

2 Combined Carotid and Coronary Artery Disease Percent Prevalence of Carotid Artery Disease in CAD Patients Prevalence of Coronary Artery Disease in Carotid Patients Huh et al. Curr Op Cardiol 2003

3 Prevalence of CAD and long-term prognosis in patients undergoing carotid artery stenting CAD prevalence: 69% (378/549 pts undergoing CAS) 18 p< p<0.001 p<0.01 MACE No-CAD CAD Cardiac Death All death No CAD CAD without significant stenosis CAD with significant stenosis Hofmann R et al.annals of Medicine

4 Prevalence of CAD and long-term prognosis in patients undergoing carotid artery stenting In the longer term, outcomes in pts undergoing CAS depend on concomitant CAD rather than neurological events, cardiac mortality and even allcad causeprevalence: mortality depending 69% (378/549 on a significant pts undergoing coronary CAS) artery stenosis 18 p< p<0.001 p<0.01 MACE No-CAD CAD Cardiac Death All death No CAD CAD without significant stenosis CAD with significant stenosis Hofmann R et al.annals of Medicine

5 Prognostic value of carotid plaque in CAD patients Event-free survival (%) X 2 =11.4; p= Follow up (months) Simple coronary and soft carotid plaques group (n=31) Simple coronary and hard carotid plaques group (n=50) Complex coronary and soft carotid plaques group (n=14) Complex coronary and hard carotid plaques group (n=49) Komorovsky et al. Am J Cardiol 2005

6 Therapeutic Strategies in Patients with Combined Coronary and Carotid Artery Disease Staged Strategy 1. CEA > CABG 2. CABG > CEA 3. CEA > PCI 4. CABG > CAS 5. CAS > CABG 6. PCI > CEA 7. CAS > PCI 8. PCI > CAS Surgical Hybrid Endovascular Revascularization PCI vs CABG & CAS vs CEA Simultaneous Strategy 9. CEA & CABG 10. CAS & PCI (or PCI & CAS) 11. Hybrid (CAS & CABG) Medical treatment Tomai F. 2008

7 Surgical approach in patients with combined coronary and carotid artery disease day death/any any stroke/myocardial infarction 11.5% 10.2% 7.3% 4 2 Synchronous CEA + CABG Staged CEA > CABG Reverse staged CABG > CEA Naylor et al, EJVES 2003 (Meta-analysis of 10 studies)

8 Surgical approach in patients with combined coronary and carotid artery disease Variable N patients (%) Death 19 (6) Neurological complications Transiet Ischaemic attack 6 (2) Reversible neurological deficit 5 (1.5) Permanent stroke 12 (4) Cardiac complications Perioperative outcome (MACCE: 12%) Myocardial Infarction 7 (2) Arrhytmia 83 (27) Transient atrio-ventricular bloc 9 (3) Event 5 and 10 yrs late actuarial cardiac and neurological event free rates 5-yrs freedom (%) 10-yrs freedom (%) Death 79.1± ±4.2 Myocardial infarction 92.3± ±2.3 Percutaneous coronary intervention Reoperative coronary grafting 99.4± ± ± ±1.4 Total stroke 98.2± ±2.4 Ipsilateral stroke 99.4± ±2.6 All events 77.8± ± consecutive patients having concurrent CEA and CABG from 1989 to 2002 Kolh PH et al Eur Heart J 2006

9 Surgical approach in patients with combined coronary and carotid artery disease 30-day outcomes in 74 consecutive pts undergoing elective synchronous CEA and off-pump CABG (MACCE: 7.9%) Events (%) Death Perioperative MI Stroke Renal Failure Borioni R et al, 2010 (submitted)

10 Hybrid approach (CAS-CABG) CABG) in patients with combined coronary and carotid artery disease Death/Stroke/MI Events Pts Risk 95%CI Mendiz 4/ Ziada 6/ Versaci 3/ Kovacic 2/ Kramer 0/ Gross 10/ Van der Heyden 31/ Abbasi 5/ Total 61/ day outcomes following staged Carotid Artery Stenting and Coronary Bypass: a meta-analysis % neurologically asymptomatic % Risk (95% CI) Naylor AR et al Eur J Vasc Endovasc Surg. 2009

11 Hybrid approach (PCI-CEA) CEA) in patients with combined coronary and carotid artery disease Staged Hybrid (PCI-CEA) CEA) Strategy Age <75 yrs vs > 75 yrs Male vs Female Hyperlipidemia vs none Diabetes vs none Hypertension vs none Lower Limb Occlusive Disease vs none Smoker vs non-smoker Coronary angiography vs none OR (95% CI) 0.98 ( ) 0.70 ( ) 1.00 ( ) 2.44 ( ) 1.23 ( ) 3.25 ( ) 2.74 ( ) 0.22 ( ) Systematic preoperative coronary angiography, possibly followed by PCI, significantly reduces the incidence of postoperative myocardial events after CEA in patients without clinical evidence of CAD Pts were operated on double antiplatelet therapy Illuminati G et al. Eur J Vasc Endovasc Surg 2010

12 Endovascular approach in patients with combined coronary and carotid artery disease Simultaneous Strategy Male, 82 yrs, CVAs, unstable angina, severe pulmonary disease, renal failure Tomai et al, Ital Heart J 2003

13 Endovascular approach in patients with combined coronary and carotid artery disease 30 day death/any any stroke/myocardial infarction * 2 Minor strokes 10 % * Simultaneous PCI + CAS 0 % Staged PCI > CAS Al-Mubarak et al, Am J Cardiol 1999

14 Assessment of clinical outcome after combined revascularization of pluri-vascular atherosclerosis The Finalized Research In ENDovascular Strategies Study Group (FRIENDS) Fausto Castriota * Bernhard Reimers ** Flavio Ribichini *** Paolo Russo **** Fabrizio Tomai ***** * Cardiovascular Unit, Villa Maria Cecilia Hospital, Cotignola ** Division of Cardiology, Ospedale Civile di Mirano, Mirano *** Dept. of Biomedical Sciences and Surgery, University of Verona **** Villa Maria Pia Hospital, Torino ***** Dept. of Cardiovascular Sciences, European Hospital, Roma

15 Combined Carotid and Coronary Artery Disease

16 Endovascular, Surgical or Hybrid Revascularization in pts with Combined Carotid and Coronary Artery Disease The Finalized Research In ENDovascular Strategies Study Group (FRIENDS) Primary endpoint: MACCE at 30 days Secondary endpoint: MACCE, major bleeding, AKI in-hospital 10 % p=0.01 % p< Surgical Endovascular Hybrid Surgical Endovascular Hybrid (185 pts) (378 pts) (89 pts) (185 pts) (378 pts) (89 pts) Ribichini F and Tomai F for the FRIENDS Study Group. EuroIntervention 2010

17 Endovascular Revascularization in pts with Combined Carotid and Coronary Artery Disease The Finalized Research In ENDovascular Strategies Study Group (FRIENDS) Primary endpoint: Death, MI and stroke at 30 days Secondary endpoint: Death, MI and stroke at 2 years 3 8 % % 7 2, ,5 1 0, D MACCE: 4.2% 2-Y MACCE:11.3% Jan 2006-Apr 2010 N= Death MI Stroke Death MI Stroke Tomai F. et al for the FRIENDS Study Group (submitted)

18 Female,, 74 yrs old recent TIA (10 days) High risk carotid plaque Chronic stable angina One-vessel disease Normal LV function Carotid first!

19 Male, 68 yrs old Previous stroke (5 months) Low risk carotid plaque NSTEMI Previous CABG Multi-vessel disease Poor LV function Coronary first!

20 Male, 74 yrs old, NSTEMI, Leriche Syndrome, left ICA 100% Staged strategy: PCI first

21 Female,, 79 yrs old, TIA, Aortic valve prostesis,, by-pass disease Staged strategy: CAS first

22 Male, 82 yrs old, unstable angina, TIAs, severe pulmonary disease, renal failure Simultaneous strategy

23 Therapeutic Strategies in Patients with Combined Coronary and Carotid Artery Disease Endovascular, Surgical or Hybrid Approach? 1. No sufficient data at the present time; however, the strategy is often dependent on the specific clinical characteristics of the patient 2. Risk stratification 3. Anatomical (endovascular vs. surgical) feasibility 4. Patient preference 5. Team experience 6. The endovascular treatment, being less invasive, may be particularly suited to these fragile and complex patients

24 ESC Guidelines: latest news European Heart Journal 2010; August 29 doi: /eurheartj/ online first ESC GUIDELINES ESC / EACTS Guidelines on Myocardial Revascularisation The Task Force on Myocardial Revascularisation of the European Society of Cardiology (ESC) and the European Association of Cardio-Thoracic Surgery (EACTS) Endorsed by European Association for Percutaneous Cardiovascular Interventions (EAPCI) New Myocardial Revascularization Guidelines have a dedicated chapter for patients needing myocardial revascularization and having concomitant carotid obstructive disease.

25 ESC Guidelines: latest news European Heart Journal 2010; August 29 doi: /eurheartj/ online first ESC GUIDELINES ESC / EACTS Guidelines on Myocardial Revascularisation

Carotid Artery Stenting Can carotid stenting before CABG reduce perioperative stroke?

Carotid Artery Stenting Can carotid stenting before CABG reduce perioperative stroke? Carotid Artery Stenting Can carotid stenting before CABG reduce perioperative stroke? Seong-Wook Park, MD, PhD, FACC,, Seoul, Korea Carotid Stenosis in Patients Undergoing CABG The reported incidence of

More information

Coronary Surgery in Woman: A Different Tissue. Friedrich Eckstein Cardiac Surgery, University Hospital Basel

Coronary Surgery in Woman: A Different Tissue. Friedrich Eckstein Cardiac Surgery, University Hospital Basel Coronary Surgery in Woman: A Different Tissue Friedrich Eckstein Cardiac Surgery, University Hospital Basel Background STS National Cardiac Surgery Database (US) for 2002 reveals a CABG operative mortality

More information

Medicare Evidence Development & Coverage Advisory Committee Management of Carotid Atherosclerosis January 25, 2012

Medicare Evidence Development & Coverage Advisory Committee Management of Carotid Atherosclerosis January 25, 2012 Medicare Evidence Development & Coverage Advisory Committee Management of Carotid Atherosclerosis January 25, 2012 The American Heart Association (AHA) and the American Stroke Association (ASA), a division

More information

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 1,871) is a regional and national referral center for percutaneous coronary intervention (PCI). A total

More information

FAME 3 Trial: FFR-Guided PCI vs. CABG

FAME 3 Trial: FFR-Guided PCI vs. CABG FAME 3 Trial: FFR-Guided PCI vs. CABG William F. Fearon, M.D. Associate Professor of Medicine Director, Interventional Cardiology Stanford University Medical Center Background: SYNTAX Trial One Year MACCE

More information

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium Background 8 th Coronary Physiology in the CathLab Course Revascularisation of intermediate stenosis can be targeted EITHER

More information

Management of Asymptomatic Carotid Artery Stenosis. Matthew Blair, D.O. Hospitalist MetroHealth hospital

Management of Asymptomatic Carotid Artery Stenosis. Matthew Blair, D.O. Hospitalist MetroHealth hospital Management of Asymptomatic Carotid Artery Stenosis Matthew Blair, D.O. Hospitalist MetroHealth hospital Objectives: For the Primary care physician to be able to: Discuss and institute appropriate medical

More information

Coronary Stenting. Dr Suneel Talwar MD MRCP Consultant Interventional Cardiologist The Dorset Heart Centre, Royal Bournemouth Hospital

Coronary Stenting. Dr Suneel Talwar MD MRCP Consultant Interventional Cardiologist The Dorset Heart Centre, Royal Bournemouth Hospital Coronary Stenting Dr Suneel Talwar MD MRCP Consultant Interventional Cardiologist The Dorset Heart Centre, Royal Bournemouth Hospital 1967 Dr. Rene Favaloro conducts the first saphenous vein graft (bypass)

More information

Medical Management of Carotid Stenosis

Medical Management of Carotid Stenosis Medical Management of Carotid Stenosis Thomas F. Rehring, MD, FACS Disclosures: None Regional Department Chief Department of Vascular Therapy Colorado Permanente Medical Group Clinical Associate Professor

More information

Carotid Endarterectomy for Symptomatic Carotid Stenosis. Where do surgeons fit best in secondary stroke prevention?

Carotid Endarterectomy for Symptomatic Carotid Stenosis. Where do surgeons fit best in secondary stroke prevention? Carotid Endarterectomy for Symptomatic Carotid Stenosis Where do surgeons fit best in secondary stroke prevention? What Plato Said Technical options for carotid endarterectomy Just what should surgeons

More information

Treatment of Diabetic Patient with Multivessel Coronary Artery Disease: the Surgeon Perspective

Treatment of Diabetic Patient with Multivessel Coronary Artery Disease: the Surgeon Perspective Treatment of Diabetic Patient with Multivessel Coronary Artery Disease: the Surgeon Perspective Fabio B. Jatene Full Professor of Cardiovascular Surgery Heart Institute - HC-FMUSP fabiojatene@incor.usp.br

More information

The German Off-Pump Coronary Artery Bypass Grafting in Elderly Patients (GOPCABE) Study

The German Off-Pump Coronary Artery Bypass Grafting in Elderly Patients (GOPCABE) Study The German Off-Pump Coronary Artery Bypass Grafting in Elderly Patients (GOPCABE) Study Prof. Dr. med. Anno Diegeler Bad Neustadt Heart Center For the GOPCABE study group Disclosures Sponsor of the study

More information

Comparison of high reloading ROsuvastatin and Atorvastatin. necrosis.

Comparison of high reloading ROsuvastatin and Atorvastatin. necrosis. Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. (ROMA II Reload) (NCT1228227)

More information

Does Asymptomatic Carotid Stenosis Matter Anymore?

Does Asymptomatic Carotid Stenosis Matter Anymore? Does Asymptomatic Carotid Stenosis Matter Anymore? David Paul Slovut, MD, PhD Associate Prof of Medicine and Surgery Co-director of TAVR program Director of Advanced Intervention Faculty Disclosure David

More information

Postoperative Myocardial Infarction: Diagnosis and Management

Postoperative Myocardial Infarction: Diagnosis and Management Postoperative Myocardial Infarction: Diagnosis and Management Todd M. Brown, MD, MSPH Chief Fellow Division of Cardiovascular Diseases December 9, 2008 CHEST PAIN NON-ANGINAL UNSURE ANGINAL STABLE ANGINA

More information

Is Carotid Revascularization Necessary Before Cardiac Surgery?

Is Carotid Revascularization Necessary Before Cardiac Surgery? Is Carotid Revascularization Necessary Before Cardiac Surgery? Siavash Saadat, MD April 27, 2015 Rutgers, The State University of New Jersey Disclosures No financial disclosures Background Optimal management

More information

Listen to your heart: Good Cardiovascular Health for Life

Listen to your heart: Good Cardiovascular Health for Life Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular

More information

Stable Ischemic Heart Disease: When and How to Revascularize. Robert N. Jones, MD

Stable Ischemic Heart Disease: When and How to Revascularize. Robert N. Jones, MD Stable Ischemic Heart Disease: When and How to Revascularize Robert N. Jones, MD 1 I have no financial disclosures to make 2 3 4 Outline Basics of coronary bypass grafting Chronic stable coronary artery

More information

How to manage patients with asymptomatic carotid disease?

How to manage patients with asymptomatic carotid disease? Casa di cura Città di Aprilia 17-10 10-0909 How to manage patients with asymptomatic carotid disease? Fausto Castriota, Armando Liso, Alessandro Furgieri and Alberto Cremonesi Interventional Cardio-Angiology

More information

Cardiovascular disease (CVD) is the leading cause of death in women, accounting for 54% of deaths in women in Europe

Cardiovascular disease (CVD) is the leading cause of death in women, accounting for 54% of deaths in women in Europe Red Alert for Women s Hearts Summary FACTS ON WOMEN AND CARDIOVASCULAR RESEARCH Cardiovascular disease (CVD) is the leading cause of death in women, accounting for 54% of deaths in women in Europe Women

More information

Cilostazol versus Clopidogrel after Coronary Stenting

Cilostazol versus Clopidogrel after Coronary Stenting Cilostazol versus Clopidogrel after Coronary Stenting Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea AMC, 2004 Background

More information

Perioperative Cardiac Evaluation

Perioperative Cardiac Evaluation Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project

More information

Combined coronary artery bypass and carotid endarterectomy: long-term results

Combined coronary artery bypass and carotid endarterectomy: long-term results PII: S0967-2109(01)00113-2 Cardiovascular Surgery, Vol. 10, No. 2, pp. 111 115, 2002 2002 The International Society for Cardiovascular Surgery Published by Elsevier Science Ltd. All rights reserved 0967-2109/02

More information

Multivessel Coronary Artery Disease: Bypass Surgery. Bruce Lytle, MD

Multivessel Coronary Artery Disease: Bypass Surgery. Bruce Lytle, MD Multivessel Coronary Artery Disease: Bypass Surgery Bruce Lytle, MD Coronary Artery Bypass Surgery Prolongs Survival Angiographic Subgroups MR (%) LMT stenosis (> 50%) 68% 3V CAD (> 50%) 42% 1/2V CAD and

More information

Carotid Artery Stenting: Basics of Intervention

Carotid Artery Stenting: Basics of Intervention Carotid Artery Stenting: Basics of Intervention Carlos Mena, MD. F.A.C.C., F.S.C.A.I Assistant Professor Department of Internal Medicine Medical Director Vascular Medicine Program Section of Cardiovascular

More information

A Retrospective Cohort Study of All-Cause Mortality and. Cardiovascular Disease in Thailand

A Retrospective Cohort Study of All-Cause Mortality and. Cardiovascular Disease in Thailand A Retrospective Cohort Study of All-Cause Mortality and Cardiovascular Events In Patients with Established Cardiovascular Disease in Thailand Tarinee Tangcharoen, MD. Division of Cardiology, Department

More information

Long-Term Outcomes of the Ross Procedure versus. Mechanical Aortic Valve Replacement

Long-Term Outcomes of the Ross Procedure versus. Mechanical Aortic Valve Replacement Long-Term Outcomes of the Ross Procedure versus Mechanical Aortic Valve Replacement A Propensity-Matched Cohort Study Amine Mazine, MD, MSc; Cedric Manlhiot, PhD; Vivek Rao, MD, PhD; Edward J Hickey, MBBS;

More information

Redo cardiac surgery

Redo cardiac surgery Results of redo cardiac surgery in the current era Bakir M. Bakir, M.D. Associate professor, Consultant Cardiac Surgery King Fahd Cardiac Center King Khalid University Hospital King Saud University Redo

More information

Main Effect of Screening for Coronary Artery Disease Using CT

Main Effect of Screening for Coronary Artery Disease Using CT Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,

More information

FFR Should be done in All Intermediate Lesions

FFR Should be done in All Intermediate Lesions FFR Should be done in All Intermediate Lesions Intracoronary Physiology Beyond Angiography Samir Alam MD,FACC,FRCP Prof Of Medicine,Cardiology Chief Of Staff American University Of Beirut Managing Stable

More information

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases ESC Guidelines on the diagnosis and treatment of peripheral artery diseases The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC) European

More information

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease PRECOMBAT Trial Seung-Whan Lee, MD, PhD On behalf

More information

Chapter 4: Cardiovascular Disease in Patients With CKD

Chapter 4: Cardiovascular Disease in Patients With CKD Chapter 4: Cardiovascular Disease in Patients With CKD The prevalence of cardiovascular disease is 68.8% among patients aged 66 and older who have CKD, compared to 34.1% among those who do not have CKD

More information

Normal GFR values are ml/min/1.73 m2 in young men, and ml/min/1.73 m2 in young women.

Normal GFR values are ml/min/1.73 m2 in young men, and ml/min/1.73 m2 in young women. Management of ACS in Patients on Hemodialysis Dr. Ahmed El Zayat. MD, MRCP Cardiology Lecturer Zagazig University Normal GFR values are 100 130 ml/min/1.73 m2 in young men, and 90 120 ml/min/1.73 m2 in

More information

Ischemic Heart Disease

Ischemic Heart Disease Ischemic Heart Disease Cardiac Catheterization Laboratory Procedures (N =,88) is a regional and national referral center for percutaneous coronary intervention (PCI). In, we performed more than, procedures

More information

Non-cardiac Surgery:Risk Assessment and Management. Benico Barzilai, M.D., F.A.C.C. Section Head Clinical Cardiology Cleveland Clinic

Non-cardiac Surgery:Risk Assessment and Management. Benico Barzilai, M.D., F.A.C.C. Section Head Clinical Cardiology Cleveland Clinic Non-cardiac Surgery:Risk Assessment and Management Benico Barzilai, M.D., F.A.C.C. Section Head Clinical Cardiology Cleveland Clinic Statement of the Problem The number of persons older than 65 years in

More information

CARDIAC RISKS OF NON CARDIAC SURGERY

CARDIAC RISKS OF NON CARDIAC SURGERY CARDIAC RISKS OF NON CARDIAC SURGERY N E W S T U D I E S & N E W G U I D E L I N E S W. B. C A L H O U N, M D, F A C C 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management

More information

CAROTID ANGIOPLASTY & STENT PLACEMENT VS. CAROTID ENDARTERECTOMY

CAROTID ANGIOPLASTY & STENT PLACEMENT VS. CAROTID ENDARTERECTOMY CAROTID ANGIOPLASTY & STENT PLACEMENT VS. CAROTID ENDARTERECTOMY Gustavo J. Rodriguez, MD Associate Professor. Neurology Department Texas Tech Health Sciences Center. Paul L. Foster School of Medicine

More information

Carotid Revascularization: Who, When, and How

Carotid Revascularization: Who, When, and How Carotid Revascularization: Who, When, and How JAMES T DEVRIES, MD, FACC, FSCAI ASSISTANT PROFESSOR OF MEDICINE GEISEL SCHOOL OF MEDICINE AT DARTMOUTH DIRECTOR, CARDIAC CATHETERIZATION LAB DARTMOUTH-HITCHCOCK

More information

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate

More information

Medicare and Department of Veterans Affairs medical benefits data

Medicare and Department of Veterans Affairs medical benefits data Medicare and Department of Veterans Affairs medical benefits data This section describes the use of cardiovascular medical services covered by Medicare and the Department of Veterans Affairs for the financial

More information

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,

More information

ISAR-CABG: Randomized, Superiority Trial of Drug-Eluting-Stent and Bare Metal Stent in Safenous Vein Graft Lesions

ISAR-CABG: Randomized, Superiority Trial of Drug-Eluting-Stent and Bare Metal Stent in Safenous Vein Graft Lesions ISAR-CABG: Randomized, Superiority Trial of Drug-Eluting-Stent and Bare Metal Stent in Safenous Vein Graft Lesions J. Mehilli, MD, G. Richardt, F-J. Neumann, S. Massberg, K-L. Laugwitz, J. Pache, J. Hausleiter,

More information

Stress Echo: Role in Pre- Operative Assessment. Dr. Rachael James MD, BSc, FRCP Consultant Cardiologist Sussex Cardiac Centre Brighton

Stress Echo: Role in Pre- Operative Assessment. Dr. Rachael James MD, BSc, FRCP Consultant Cardiologist Sussex Cardiac Centre Brighton Stress Echo: Role in Pre- Operative Assessment Dr. Rachael James MD, BSc, FRCP Consultant Cardiologist Sussex Cardiac Centre Brighton TlkO Talk Outline Types stress echo Dobutamine stress echo for ischaemia

More information

ANT IPLA TELET ANTIPLATELET THERAPY TELE LA ANTIP

ANT IPLA TELET ANTIPLATELET THERAPY TELE LA ANTIP ANTIPLATELET GUIDELINES ANTIPLATELET THERAPY Focused 2012 Update of the Canadian Cardiovascular Society Guidelines for the Use of Antiplatelet Therapy ANTIPLATELET GUIDELINES For more information, please

More information

Stable Coronary Artery Disease Optimal Medical Therapy vs. Revascularization

Stable Coronary Artery Disease Optimal Medical Therapy vs. Revascularization Stable Coronary Artery Disease Optimal Medical Therapy vs. Revascularization RESCUE Investigators Meeting Kreton Mavromatis MD FACC Atlanta VA Medical Center Emory University School of Medicine Overview

More information

Ischemic vs. Embolic Stroke

Ischemic vs. Embolic Stroke Ischemic vs. Embolic Stroke Paul M. Katz, M.D. Director, Temple Stroke Program Professor Department of Neurology Temple University School of Medicine Stroke: Incidence and Cost in the United States 795,000

More information

Patients with heart disease who need non cardiac surgery?

Patients with heart disease who need non cardiac surgery? How should I manage Patients with heart disease who need non cardiac surgery? Dr Bethan Freestone Birmingham Heartlands Cardiology update day 10 October 2016 Learning objectives How to go about evaluating

More information

Valve Surgery Volume. 29.5% Isolated Primary Valve Surgeries (N = 831) 42.5% Combined Primary Valve Surgeries (N = 1,199)

Valve Surgery Volume. 29.5% Isolated Primary Valve Surgeries (N = 831) 42.5% Combined Primary Valve Surgeries (N = 1,199) Valve Disease Valve Surgery 27 211 3, 2, 1, 27 28 29 21 211 In 211, Cleveland Clinic surgeons performed 2,816 valve surgeries. This includes 2,3 primary operations and 786 reoperations. Cleveland Clinic

More information

ANGIOGRAPHIC PROFILE OF LEFT MAIN CORONARY ARTERY (LMCA) STENOSIS Malladi Srinivasa Rao 1

ANGIOGRAPHIC PROFILE OF LEFT MAIN CORONARY ARTERY (LMCA) STENOSIS Malladi Srinivasa Rao 1 ANGIOGRAPHIC PROFILE OF LEFT MAIN CORONARY ARTERY (LMCA) STENOSIS Malladi Srinivasa Rao 1 HOW TO CITE THIS ARTICLE: Malladi Srinivasa Rao. Angiographic Profile of Left Main Coronary Artery (LMCA) Stenosis.

More information

Carotid Artery Disease: Management Options. W. Todd Bohannon, MD Division of Vascular Surgery Temple, Texas S&W Stroke Symposium 2013 June 7 th, 2013

Carotid Artery Disease: Management Options. W. Todd Bohannon, MD Division of Vascular Surgery Temple, Texas S&W Stroke Symposium 2013 June 7 th, 2013 Carotid Artery Disease: Management Options W. Todd Bohannon, MD Division of Vascular Surgery Temple, Texas S&W Stroke Symposium 2013 June 7 th, 2013 Objectives Evaluation of carotid disease: Who do we

More information

Impella CP vs. IABP in AMI with Cardiogenic Shock

Impella CP vs. IABP in AMI with Cardiogenic Shock Impella CP vs. IABP in AMI with Cardiogenic Shock On behalf of the IMPRESS in Severe Shock Trial investigators José P.S. Henriques Academic Medical Center University of Amsterdam The Netherlands Disclosure

More information

Experience of Modena Hospital

Experience of Modena Hospital Acute treatment of carotid artery disease Experience of Modena Hospital Vascular Surgeon 02 Acute carotid treatment A story from the past Mrs A, a housewife, aged 66, was in bed Dec. 26, 1953, recovering

More information

ABSTRACT. Key words: CAS: Carotid Artery Stenosis, CAD: Coronary Artery Disease, CABG: Coronary Artery Bypass

ABSTRACT. Key words: CAS: Carotid Artery Stenosis, CAD: Coronary Artery Disease, CABG: Coronary Artery Bypass Pre-operative Carotid Doppler Ultrasound Scanning among Patients who Underwent Cardiac Surgical Procedures at Queen Alia Heart Institute, Is It Necessary? Mohammad Al-Fayez MD*, Zeyad Al-Shawabkah MD*,

More information

Paul McWhirter, MD, FACC Medical Director Non-Invasive Cardiology John Muir Health Concord Campus

Paul McWhirter, MD, FACC Medical Director Non-Invasive Cardiology John Muir Health Concord Campus ACO 30 Antiplatelet Therapy in Ischemic Vascular Disease Or How using aspirin pays in quality and shared-savings Paul McWhirter, MD, FACC Medical Director Non-Invasive Cardiology John Muir Health Concord

More information

Antonio Colombo MD on behalf of the SECURITY Investigators

Antonio Colombo MD on behalf of the SECURITY Investigators Second Generation Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy - The SECURITY Randomized Clinical Trial Antonio Colombo MD on behalf of the SECURITY

More information

Statins: Can there be too much of a good thing?

Statins: Can there be too much of a good thing? Statins: Can there be too much of a good thing? Spoiler alert No Oh Contraire Haaaaiiiiiiile No! Frequently under prescribing statin therapy! Typical Case 68 YO Smoker ACS Multiple prior PCI s Multiple

More information

Optimal Revascularization Strategy in Patients With. 3-Vessel and/or Left Main Disease

Optimal Revascularization Strategy in Patients With. 3-Vessel and/or Left Main Disease Final Five-Year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients With 3-Vessel and/or Left Main Disease On behalf of the SYNTAX investigators SYNTAX 5-year Outcomes ESC 212

More information

Επιλογή ασθενών για επαναιμάτωση στις χρόνιες ολικές αποφράξεις. Γιώργος Κ. Καραβόλιας Επεμβατικός Καρδιολόγος Ωνάσειο Καρδιοχειρουργικό Κέντρο

Επιλογή ασθενών για επαναιμάτωση στις χρόνιες ολικές αποφράξεις. Γιώργος Κ. Καραβόλιας Επεμβατικός Καρδιολόγος Ωνάσειο Καρδιοχειρουργικό Κέντρο Επιλογή ασθενών για επαναιμάτωση στις χρόνιες ολικές αποφράξεις Γιώργος Κ. Καραβόλιας Επεμβατικός Καρδιολόγος Ωνάσειο Καρδιοχειρουργικό Κέντρο Επιλογή ασθενών για επαναιμάτωση στις χρόνιες ολικές αποφράξεις

More information

Discordance of CTA / Nuclear/ Cath which one to Believe?

Discordance of CTA / Nuclear/ Cath which one to Believe? Discordance of CTA / Nuclear/ Cath which one to Believe? Khalid ALNemer MD, FRCPC, FACC, FASCI, FASNC, FSCCT. Interventional,CT/Nuclear Cardiologist. Chairman of Professional Education Committee SHA. Chairman

More information

CURRENT STATUS OF CAROTID ARTERY STENTING TRIALS, REGISTRIES, AND CMS

CURRENT STATUS OF CAROTID ARTERY STENTING TRIALS, REGISTRIES, AND CMS CURRENT STATUS OF CAROTID ARTERY STENTING TRIALS, REGISTRIES, AND CMS No Conflict Girma Tefera, MD University of Wisconsin School of Medicine and Public Health UCSF Vascular Symposium 2014 OUTLINE Historic

More information

Surgeons Role in Atrial Fibrillation

Surgeons Role in Atrial Fibrillation Atrial Fibrillation Surgeons Role in Atrial Fibrillation Steven J Feldhaus, MD, FACS 2015 Cardiac Symposium September 18, 2015 Stages of Atrial Fibrillation Paroxysmal (Intermittent) Persistent (Continuous)

More information

Revisiting the Definition of Type 2 Myocardial Infarction: When is an abnormal troponin value not an MI?

Revisiting the Definition of Type 2 Myocardial Infarction: When is an abnormal troponin value not an MI? Revisiting the Definition of Type 2 Myocardial Infarction: When is an abnormal troponin value not an MI? Joseph S. Alpert, MD Professor of Medicine, University of Arizona College of Medicine, Tucson, AZ,

More information

Detailed Order Request Checklists for Cardiology

Detailed Order Request Checklists for Cardiology Next Generation Solutions Detailed Order Request Checklists for Cardiology 8600 West Bryn Mawr Avenue South Tower Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable 2015

More information

The VeriQ system for assessing graft flow during coronary artery bypass graft surgery

The VeriQ system for assessing graft flow during coronary artery bypass graft surgery The VeriQ system for assessing graft flow during coronary artery bypass graft surgery Implementing NICE guidance November 2011 NICE medical technology guidance 8 What this presentation covers Background

More information

Prof Ribichini is providing this presentation on behalf of Volcano Europe

Prof Ribichini is providing this presentation on behalf of Volcano Europe 1 Prof Ribichini is providing this presentation on behalf of Volcano Europe Volcano & Philips Stronger Together Healthy Living Prevention Diagnosis Treatment Recovery Home Care Health & Wellness 23% Image

More information

STROKE. Stroke Prevention Guidelines. Disclosures 2/21/2017

STROKE. Stroke Prevention Guidelines. Disclosures 2/21/2017 Miami Cardiac and Vascular Institute Stroke Prevention Guidelines Ian Del Conde, MD, FACC Vascular Medicine and Cardiology Miami Cardiac and Vascular Institute Baptist Hospital, Miami HeartWell, LLP Janssen:

More information

The relationship between Coronary Angiography and Class of Angina Abdul-Kareem Al Shimary * CABM

The relationship between Coronary Angiography and Class of Angina Abdul-Kareem Al Shimary * CABM * CABM Abstract: Background: Coronary heart disease is the most common form of heart disease and the single most important cause of death worldwide. Coronary arteriography provides detailed anatomical

More information

Clinical characteristics & impact of Peripheral Vascular Disease in Diabetes. Keimyung University Hye Soon Kim

Clinical characteristics & impact of Peripheral Vascular Disease in Diabetes. Keimyung University Hye Soon Kim Clinical characteristics & impact of Peripheral Vascular Disease in Diabetes Keimyung University Hye Soon Kim Peripheral Vascular Disease Diseases to arteries & veins outside thoracic region Main cause

More information

Thoracic and Cardiac Surgery Volume. Other Cleveland Clinic hospitals Main campus. Surgical Procedure Volume by Type and Location (N = 13,714)

Thoracic and Cardiac Surgery Volume. Other Cleveland Clinic hospitals Main campus. Surgical Procedure Volume by Type and Location (N = 13,714) Surgical Overview Thoracic and Cardiac Surgery 7% Reoperations accounted for 7% of all cardiac surgeries performed at s main campus in. Reoperations are more complex and are associated with greater risk

More information

Exercise Stress Testing. George Le-Bert, DO, FACC Baptist Heart Specialists

Exercise Stress Testing. George Le-Bert, DO, FACC Baptist Heart Specialists Exercise Stress Testing George Le-Bert, DO, FACC Baptist Heart Specialists ACC/AHA-Guidelines The Stress Test has two roles in clinical care: 1. Diagnostic evaluation. 2. Assessment of long-term risk of

More information

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania DUAL ANTIPLATELET THERAPY Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania DUAL ANTIPLATELET THERAPY (DAPT) Dual antiplatelet regimen

More information

Antiplatelet Therapy Before and After CABG

Antiplatelet Therapy Before and After CABG Antiplatelet Therapy Before and After CABG Miguel Sousa Uva Hospital Cruz Vermelha Conflict of Interest: None Why Is Antiplatelet Therapy Important in CABG? CABG Required in 10-15% after ACS CABG Early

More information

Long-term adherence to statins and outcome after acute myocardial infarction: A nationwide French survey of administrative data.

Long-term adherence to statins and outcome after acute myocardial infarction: A nationwide French survey of administrative data. Long-term adherence to statins and outcome after acute myocardial infarction: A nationwide French survey of administrative data. Anke Neumann, PhD, Philippe Tuppin, MD, Nicolas Danchin, MD, Christine De

More information

Disclosures (with apologies to the Wizard of Oz) A Brain; Heart; and COURAGE

Disclosures (with apologies to the Wizard of Oz) A Brain; Heart; and COURAGE 2008 Update: Tools for the Management of Stable Angina Disclosures (with apologies to the Wizard of Oz) A Brain; Heart; and COURAGE Daniel Edmundowicz, MS, MD, FACC Associate Professor Of Medicine Director,

More information

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone James A. Stone BPHE, BA, MSc, MD, PhD, FRCPC, FAACVPR, FACC Clinical Professor of Medicine, University of Calgary Total Cardiology, Calgary Acknowledgements and Disclosures Acknowledgements Jacques Genest

More information

Cardiac Pulmonary Edema and Cardiogenic Shock

Cardiac Pulmonary Edema and Cardiogenic Shock Cardiac Pulmonary Edema and Cardiogenic Shock 胡為雄 Frank-Starling Law Stroke Volume End-Diastolic Pressure In the normal heart, the diastolic volume (preload) is the principal force that governs the strength

More information

WENBIT Western Norway B-vitamin Intervention Trial

WENBIT Western Norway B-vitamin Intervention Trial WENBIT Western Norway B-vitamin Intervention Trial Marta Ebbing, MD Department of Heart Disease, Haukeland University Hospital, Bergen The WENBIT Study Group Background and Objectives Background Homocysteine-hypothesis

More information

Carotid Artery Stenting and Cardiac Surgery

Carotid Artery Stenting and Cardiac Surgery JACC: CARDIOVASCULAR INTERVENTIONS VOL. 4, NO. 11, 2011 2011 BY THE AMERICAN COLLEGE OF CARDIOLOGY FOUNDATION ISSN 1936-8798/$36.00 PUBLISHED BY ELSEVIER INC. DOI: 10.1016/j.jcin.2011.07.012 Carotid Artery

More information

Prognostic impact of uric acid in patients with stable coronary artery disease

Prognostic impact of uric acid in patients with stable coronary artery disease Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,

More information

Current and Emerging Therapies in the Management of Ischemic Heart Disease. Mohammad Bashir, MBBS Assistant Professor, Cardiothoracic Surgery

Current and Emerging Therapies in the Management of Ischemic Heart Disease. Mohammad Bashir, MBBS Assistant Professor, Cardiothoracic Surgery Current and Emerging Therapies in the Management of Ischemic Heart Disease Mohammad Bashir, MBBS Assistant Professor, Cardiothoracic Surgery Case 1 51 year old male patient History of Paroxysmal atrial

More information

Treatment of Popliteal Artery Aneurysm Disease

Treatment of Popliteal Artery Aneurysm Disease Treatment of Popliteal Artery Aneurysm Disease Luke Marone MD,FACS Professor of Surgery & Radiology Chief of Vascular and Endovascular Surgery Co-Director Heart and Vascular Institute WVU Medicine Disclosures

More information

Cardiac Rehab Why Are We Underutilizing This Powerful Intervention?

Cardiac Rehab Why Are We Underutilizing This Powerful Intervention? Cardiac Rehab Why Are We Underutilizing This Powerful Intervention? August 20, 2016 Chad Raymond, DO, FACC Director Cardiac Rehabilitation CCF Euclid and South Pointe Hospitals Goals/Objectives Really,

More information

on post - PCI Patients

on post - PCI Patients LOGO Perioperative Management on post - PCI Patients Hari Hendriarto Satoto Department & Intensive Therapy Kariadi Hospital / Diponegoro University Introduction Coronary artery disease (CAD) syndromes

More information

Indications and Applications of Stress Testing, Cardiac MRI and Cardiac CTA. Kevin M Hayes D.O.

Indications and Applications of Stress Testing, Cardiac MRI and Cardiac CTA. Kevin M Hayes D.O. Indications and Applications of Stress Testing, Cardiac MRI and Cardiac CTA Kevin M Hayes D.O. Objectives Description of cardiac stress test available Indications for use and prognostic information What

More information

Acute Coronary Syndromes & Thrombolytics

Acute Coronary Syndromes & Thrombolytics Acute Coronary Syndromes & Thrombolytics Dr. Anu Tunuguntla MD Interventional Cardiology Nebraska Heart Institute Chair Mission: Lifeline Steering Committee Disclosures I have no financial or commercial

More information

Computed tomography coronary angiography in patients with suspected coronary artery disease

Computed tomography coronary angiography in patients with suspected coronary artery disease Computed tomography coronary angiography in patients with suspected coronary artery disease Prof. Dr. Stephen Schröder, EC, FESC Department of Cardiology Klinik am Eichert Göppingen Germany -No conflicts

More information

Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial

Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial Michael J. Mack, MD on behalf of The PARTNER Trial Investigators ACC 2015

More information

Institutional and national trends in isolated mitral valve surgery over the past decade Niv Ad, Scott D. Barnett, Alan M. Speir and Paul S.

Institutional and national trends in isolated mitral valve surgery over the past decade Niv Ad, Scott D. Barnett, Alan M. Speir and Paul S. Institutional and national trends in isolated mitral valve surgery over the past decade Niv Ad, Scott D. Barnett, Alan M. Speir and Paul S. Massimiano Inova Heart and Vascular Institute, Falls Church,

More information

1. Whether the risks of stent thrombosis (ST) and major adverse cardiovascular and cerebrovascular events (MACCE) differ from BMS and DES

1. Whether the risks of stent thrombosis (ST) and major adverse cardiovascular and cerebrovascular events (MACCE) differ from BMS and DES 1 Comparison of Ischemic and Bleeding Events After Drug- Eluting Stents or Bare Metal Stents in Subjects Receiving Dual Antiplatelet Therapy: Results from the Randomized Dual Antiplatelet Therapy (DAPT)

More information

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-elevation myocardial infarction 3 year follow-up of the randomised trial Peter Clemmensen, Henning Kelbæk,

More information

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize

More information

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG

More information

2016 Radiology Preferred Specialty Measure Set

2016 Radiology Preferred Specialty Measure Set Measures Primarily Relevant to Diagnostic Radiologists 147 0511 Claims, Registry 225 0509 Claims, Registry Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy:

More information

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) March 2014 2014 MVP Health Care, Inc. CHAPTER 9 CHAPTER SPECIFIC CATEGORY CODE BLOCKS I00-I02 Acute rheumatic fever I05-I09 Chronic rheumatic heart

More information

06 Validation of risk prediction model

06 Validation of risk prediction model HA Territory-wide PCI Audit 2003-06 06 Validation of risk prediction model PCI Audit Working Group Central Committee (Cardiac Services) HA Convention 2007 Background Participants: All HA hospitals via

More information

VASCULAR SURGERY. 4. Assess the vascular system by appropriate skills in history-taking and in clinical examination.

VASCULAR SURGERY. 4. Assess the vascular system by appropriate skills in history-taking and in clinical examination. VASCULAR SURGERY PGY-1 Medical Knowledge 1. Describe human arterial and venous anatomy. 2. Describe basic arterial and venous hemodynamics. 3. Review the basic clinical manifestations of vascular disorders.

More information

Management of superficial femoral artery occlusive disease

Management of superficial femoral artery occlusive disease Management of superficial femoral artery occlusive disease Vascular team work Al-Hussein University Hospital Dr. Mahsoub M Amin Head of General and Vascular Surgery Department Al-Azhar University (Assuit)

More information